Annual CFO
-$39.53 M
-$11.10 M-39.06%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual cash flow from operations is -$39.53 million, with the most recent change of -$11.10 million (-39.06%) on December 31, 2023.
- During the last 3 years, ELDN annual CFO has fallen by -$24.32 million (-159.84%).
- ELDN annual CFO is now -702.90% below its all-time high of -$4.92 million, reached on December 31, 2016.
Performance
ELDN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$11.77 M
-$4.00 M-51.39%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly cash flow from operations is -$11.77 million, with the most recent change of -$4.00 million (-51.39%) on September 30, 2024.
- Over the past year, ELDN quarterly CFO has increased by +$482.00 thousand (+3.93%).
- ELDN quarterly CFO is now -255.30% below its all-time high of $7.58 million, reached on June 30, 2016.
Performance
ELDN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$37.41 M
+$482.00 K+1.27%
September 30, 2024
Summary
- As of February 7, 2025, ELDN TTM cash flow from operations is -$37.41 million, with the most recent change of +$482.00 thousand (+1.27%) on September 30, 2024.
- Over the past year, ELDN TTM CFO has increased by +$2.46 million (+6.17%).
- ELDN TTM CFO is now -1050.83% below its all-time high of $3.94 million, reached on March 31, 2017.
Performance
ELDN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ELDN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.1% | +3.9% | +6.2% |
| 3 y3 years | -159.8% | +3.9% | +6.2% |
| 5 y5 years | -232.4% | +3.9% | +6.2% |
ELDN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.1% | at low | -157.5% | +3.9% | -32.9% | +6.2% |
| 5 y | 5-year | -185.3% | at low | -1997.9% | +3.9% | -379.6% | +6.2% |
| alltime | all time | -702.9% | +4.1% | -255.3% | +3.9% | -1050.8% | +9.3% |
Eledon Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.77 M(+51.4%) | -$37.41 M(-1.3%) |
| Jun 2024 | - | -$7.77 M(-11.1%) | -$37.90 M(-1.2%) |
| Mar 2024 | - | -$8.74 M(-4.3%) | -$38.34 M(-3.0%) |
| Dec 2023 | -$39.53 M(+39.1%) | -$9.13 M(-25.5%) | -$39.53 M(-0.9%) |
| Sep 2023 | - | -$12.25 M(+49.0%) | -$39.88 M(+23.9%) |
| Jun 2023 | - | -$8.22 M(-17.2%) | -$32.20 M(+6.6%) |
| Mar 2023 | - | -$9.92 M(+4.7%) | -$30.19 M(+6.2%) |
| Dec 2022 | -$28.42 M(-1.7%) | -$9.48 M(+107.4%) | -$28.42 M(+1.0%) |
| Sep 2022 | - | -$4.57 M(-26.5%) | -$28.15 M(-8.2%) |
| Jun 2022 | - | -$6.22 M(-23.8%) | -$30.67 M(-3.9%) |
| Mar 2022 | - | -$8.16 M(-11.4%) | -$31.90 M(+10.3%) |
| Dec 2021 | -$28.91 M(+90.1%) | -$9.21 M(+29.8%) | -$28.91 M(-0.8%) |
| Sep 2021 | - | -$7.09 M(-4.7%) | -$29.14 M(+28.9%) |
| Jun 2021 | - | -$7.45 M(+44.1%) | -$22.61 M(+24.3%) |
| Mar 2021 | - | -$5.17 M(-45.2%) | -$18.18 M(+19.5%) |
| Dec 2020 | -$15.21 M(+9.8%) | -$9.43 M(+1581.5%) | -$15.21 M(+95.0%) |
| Sep 2020 | - | -$561.00 K(-81.4%) | -$7.80 M(-23.0%) |
| Jun 2020 | - | -$3.02 M(+37.5%) | -$10.13 M(-15.8%) |
| Mar 2020 | - | -$2.20 M(+8.6%) | -$12.03 M(-13.2%) |
| Dec 2019 | -$13.86 M | -$2.02 M(-30.0%) | -$13.86 M(-8.8%) |
| Sep 2019 | - | -$2.89 M(-41.3%) | -$15.19 M(-0.3%) |
| Jun 2019 | - | -$4.92 M(+22.3%) | -$15.23 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.02 M(+20.0%) | -$13.64 M(+14.7%) |
| Dec 2018 | -$11.89 M(-20.4%) | -$3.35 M(+14.2%) | -$11.89 M(+6.7%) |
| Sep 2018 | - | -$2.94 M(-12.0%) | -$11.15 M(-4.1%) |
| Jun 2018 | - | -$3.33 M(+46.8%) | -$11.63 M(-28.8%) |
| Mar 2018 | - | -$2.27 M(-13.0%) | -$16.33 M(+9.3%) |
| Dec 2017 | -$14.94 M(+203.5%) | -$2.61 M(-23.6%) | -$14.94 M(+9.8%) |
| Sep 2017 | - | -$3.42 M(-57.5%) | -$13.61 M(+16.6%) |
| Jun 2017 | - | -$8.03 M(+810.5%) | -$11.67 M(-396.7%) |
| Mar 2017 | - | -$882.00 K(-31.2%) | $3.94 M(-179.9%) |
| Dec 2016 | -$4.92 M(-88.1%) | -$1.28 M(-13.3%) | -$4.92 M(-60.7%) |
| Sep 2016 | - | -$1.48 M(-119.5%) | -$12.52 M(-41.2%) |
| Jun 2016 | - | $7.58 M(-177.8%) | -$21.29 M(-46.6%) |
| Mar 2016 | - | -$9.74 M(+9.7%) | -$39.87 M(-3.3%) |
| Dec 2015 | -$41.24 M(+95.2%) | -$8.88 M(-13.4%) | -$41.24 M(+6.2%) |
| Sep 2015 | - | -$10.25 M(-6.9%) | -$38.82 M(+17.5%) |
| Jun 2015 | - | -$11.01 M(-0.9%) | -$33.03 M(+20.3%) |
| Mar 2015 | - | -$11.10 M(+71.9%) | -$27.45 M(+30.0%) |
| Dec 2014 | -$21.12 M(+36.5%) | -$6.46 M(+44.7%) | -$21.12 M(+44.1%) |
| Sep 2014 | - | -$4.46 M(-17.7%) | -$14.66 M(+43.8%) |
| Jun 2014 | - | -$5.42 M(+13.5%) | -$10.20 M(+113.5%) |
| Mar 2014 | - | -$4.78 M | -$4.78 M |
| Dec 2013 | -$15.48 M(+65.8%) | - | - |
| Dec 2012 | -$9.33 M | - | - |
FAQ
- What is Eledon Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual CFO year-on-year change?
- What is Eledon Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly CFO year-on-year change?
- What is Eledon Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals TTM CFO year-on-year change?
What is Eledon Pharmaceuticals annual cash flow from operations?
The current annual CFO of ELDN is -$39.53 M
What is the all time high annual CFO for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual cash flow from operations is -$4.92 M
What is Eledon Pharmaceuticals annual CFO year-on-year change?
Over the past year, ELDN annual cash flow from operations has changed by -$11.10 M (-39.06%)
What is Eledon Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ELDN is -$11.77 M
What is the all time high quarterly CFO for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly cash flow from operations is $7.58 M
What is Eledon Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ELDN quarterly cash flow from operations has changed by +$482.00 K (+3.93%)
What is Eledon Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ELDN is -$37.41 M
What is the all time high TTM CFO for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high TTM cash flow from operations is $3.94 M
What is Eledon Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ELDN TTM cash flow from operations has changed by +$2.46 M (+6.17%)